Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$906,362
-$80,777 QoQ
Shares Held
15,730
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,226
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SMITH, MOORE & CO. holds $27,430,178 across 9 Drug Manufacturers - General names. BMY ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,543 | $7,182,560 | |
| 2 | LLY |
ELI LILLY & Co
|
5,912 | $7,091,030 | |
| 3 | JNJ |
Johnson & Johnson
|
23,180 | $5,887,024 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,976 | $3,080,916 | |
| 5 | AMGN |
Amgen Inc
|
4,729 | $1,712,465 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
15,730 | $906,362 | |
| 7 | PFE |
Pfizer Inc
|
32,201 | $775,400 | |
| 8 | AZN |
Astrazeneca PLC
|
2,644 | $501,355 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $906,362 | 15,730 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $987,139 | 16,276 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $905,598 | 16,789 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $874,353 | 19,387 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,165,998 | 25,189 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,613,246 | 26,451 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,633,283 | 28,877 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,543,714 | 29,836 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,249,762 | 30,093 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,743,657 | 32,153 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,693,743 | 33,010 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,917,119 | 33,031 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,122,692 | 33,193 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,227,346 | 32,136 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,281,102 | 31,704 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,293,363 | 32,260 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,533,377 | 32,901 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,524,501 | 34,568 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,158,931 | 34,626 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,974,857 | 33,376 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,147,795 | 32,143 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,048,631 | 32,451 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,319,936 | 21,279 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,252,826 | 20,780 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $992,955 | 16,887 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,122,547 | 20,139 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||